Merck & Co., Inc. (MRK) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free MRK Stock Alerts $131.20 +0.48 (+0.37%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMerck & Co., Inc. (NYSE:MRK) Shares Acquired by PFG Investments LLCmarketbeat.com - April 27 at 9:58 PMMerck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Thinkfinance.yahoo.com - April 27 at 10:02 AMMerck & Co., Inc. Q1 Earnings Transcriptmarketbeat.com - April 27 at 7:04 AMTruist Financial Corp Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 27 at 12:41 AMMerck & Co., Inc. (NYSE:MRK) Announces Quarterly Earnings Results, Beats Estimates By $0.13 EPSmarketbeat.com - April 26 at 3:51 PMTruist Financial Boosts Merck & Co., Inc. (NYSE:MRK) Price Target to $143.00marketbeat.com - April 26 at 12:52 PMBank Julius Baer & Co. Ltd Zurich Sells 1,166,230 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 25 at 8:21 PMMerck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlookbenzinga.com - April 25 at 12:55 PMHeard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharmafinance.yahoo.com - April 25 at 12:55 PMMerck's Cancer Drug and Vaccine Sales Drive Better-Than-Expected Resultsinvestopedia.com - April 25 at 11:36 AMMerck jumps on profit beat as Bristol Myers Squibb slips to a lossproactiveinvestors.com - April 25 at 9:51 AMMerck & Co., Inc. (NYSE:MRK) Issues FY24 Earnings Guidancemarketbeat.com - April 25 at 9:25 AMMerck’s first-quarter results beat expectations amid healthy vaccine-sales growthmarketwatch.com - April 25 at 7:55 AMMerck Lifts FY24 Outlook After Higher Q1 Earnings, Above Market; Stock Up In Pre-marketmarkets.businessinsider.com - April 25 at 7:55 AMMerck raises 2024 profit forecast on strong sales of cancer drug Keytrudafinance.yahoo.com - April 25 at 7:55 AMUPDATE 1-Merck raises 2024 profit forecast on strong sales of cancer drug Keytrudafinance.yahoo.com - April 25 at 7:55 AMMerck & Co., Inc. (NYSE:MRK) Releases FY 2024 Earnings Guidancemarketbeat.com - April 25 at 7:24 AMMerck raises 2024 profit forecast on strong cancer, HPV drugs salesreuters.com - April 25 at 6:33 AMMerck beats earnings expectations, raises outlook on strong Keytruda and vaccine salescnbc.com - April 25 at 6:32 AMMerck Announces First-Quarter 2024 Financial Resultsbusinesswire.com - April 25 at 6:30 AMPoplar Forest Capital LLC Sells 98,453 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 24 at 11:57 PMMerck Q1 Earnings Preview: Strong quarter expectations on the back of core products' growthmsn.com - April 24 at 12:11 PMBrokers Offer Predictions for Merck & Co., Inc.'s Q4 2025 Earnings (NYSE:MRK)americanbankingnews.com - April 24 at 2:56 AMAlaska Permanent Fund Corp Purchases 6,269 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 24 at 12:51 AMInvestor Alert: Prepare for the Market Crash With These 3 Stocksinvestorplace.com - April 23 at 5:11 PM3 Underappreciated Pharmaceutical Stocks to Buy Before They Surgeinvestorplace.com - April 23 at 3:00 PMHere’s Why Merck & Co. (MRK) Outperformed in Q1finance.yahoo.com - April 23 at 11:09 AMMerck & Co., Inc. (NYSE:MRK) Expected to Earn Q4 2025 Earnings of $2.39 Per Sharemarketbeat.com - April 23 at 6:31 AMIllinois Municipal Retirement Fund Has $51.80 Million Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 22 at 9:59 PMQ3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)americanbankingnews.com - April 22 at 1:52 AMFoundry Partners LLC Lowers Stock Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 21 at 10:35 PMCwm LLC Acquires 6,969 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 20 at 8:22 PMMerck & Co., Inc. (NYSE:MRK) Stock Rating Reaffirmed by Cantor Fitzgeraldamericanbankingnews.com - April 20 at 5:16 AMJ.W. Cole Advisors Inc. Acquires 8,241 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 20 at 12:54 AMCramer's week ahead: Earnings from Tesla, Merck and Big Techcnbc.com - April 19 at 7:33 PMHealth Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapyfinance.yahoo.com - April 19 at 7:38 AMMerck & Co., Inc. (NYSE:MRK) Given Average Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 19 at 4:46 AMMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Fidelis Capital Partners LLCmarketbeat.com - April 18 at 7:04 PMCantor Fitzgerald Reiterates Overweight Rating for Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 18 at 10:35 AMMerck & Co., Inc. (MRK) Set to Announce Earnings on Thursdayamericanbankingnews.com - April 18 at 1:08 AMDaiwa Securities Group Inc. Has $34.99 Million Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 17 at 6:51 PMMerck Earnings Preview: Not Much To Fear, Plenty To Look Forward Toseekingalpha.com - April 17 at 3:52 PMWant $2000 In Passive Income? Invest $1000 Into These Dividend Stocks247wallst.com - April 17 at 9:35 AMMerck Insiders Sold US$15m Of Shares Suggesting Hesitancyfinance.yahoo.com - April 17 at 8:09 AMComing FDA Approvals Could Send These 3 Drug Stocks Soaringinvestorplace.com - April 17 at 8:00 AM6 Gold Standard Dividend Stocks Passive Income Investors Need to Buy247wallst.com - April 17 at 7:58 AMZurcher Kantonalbank Zurich Cantonalbank Purchases 50,423 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 16 at 5:21 PM3 Dow Stocks to Buy Now: Q2 Editioninvestorplace.com - April 16 at 3:17 PMMerck & Co., Inc. (NYSE:MRK) Holdings Reduced by Donaldson Capital Management LLCmarketbeat.com - April 15 at 5:37 PMBetter Growth Play: Merck or The Vanguard Growth Index Fund?fool.com - April 15 at 9:00 AM Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Medicare Supplement Insurance? (Ad)Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here MRK Media Mentions By Week MRK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.860.32▲Average Medical News Sentiment MRK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼4115▲MRK Articles Average Week Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AbbVie News Johnson & Johnson News Pfizer News Bristol-Myers Squibb News Eli Lilly and Company News AstraZeneca News Novartis News Abbott Laboratories News Sanofi News Vertex Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRK) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
